Huron Consulting Group (HURN): Valuation Check After New NLHS Digital Health Collaboration Announcement

Simply Wall St

Huron Consulting Group (HURN) is back in the spotlight after joining Keyin College, Vantiq, and Newfoundland and Labrador Health Services in a new digital health collaboration under NLHS's 2025 to 2026 Innovation Strategy.

See our latest analysis for Huron Consulting Group.

Investors seem to be rewarding Huron for exactly these kinds of healthcare and digital transformation wins. The latest share price is $166.23, with a strong year to date share price return of 34.81 percent and a standout five year total shareholder return of 228.84 percent, suggesting momentum is firmly building rather than fading.

If this kind of digital health growth story interests you, it could be a good moment to explore other healthcare names using healthcare stocks and see what else fits your watchlist.

With revenue and earnings still growing faster than many peers, yet the stock already near analyst targets, the key question now is simple: Is Huron still mispriced, or is the market already banking on years of future growth?

Most Popular Narrative Narrative: 6.8% Undervalued

Against a last close of $166.23, the most followed narrative points to a fair value of $178.33, implying the market is still playing catch up.

Strategic and disciplined acquisitions (e.g., Eclipse Insights, Treliant, AXIA) are broadening Huron's offerings, deepening expertise in underpenetrated markets, and diversifying revenue streams, which is expected to enhance overall growth, operating leverage, and financial resilience over the long term.

Read the complete narrative.

Curious how this acquisition spree, margin uplift, and richer future earnings multiple all fit together into that higher fair value tag? The full narrative connects every dot without holding back the bold assumptions driving this call.

Result: Fair Value of $178.33 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, policy driven funding cuts or prolonged pauses in healthcare digital projects could quickly erode Huron's growth momentum and challenge this undervaluation thesis.

Find out about the key risks to this Huron Consulting Group narrative.

Build Your Own Huron Consulting Group Narrative

If you see Huron differently or prefer to dive into the numbers yourself, you can spin up a full narrative in just minutes, Do it your way.

A great starting point for your Huron Consulting Group research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Looking for your next investing edge

Before you move on, lock in your next idea using the Simply Wall Street Screener so strong opportunities reach you before the wider market reacts.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Huron Consulting Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com